MRNA · 8-K · 20261106PR000194
Net Income and Profitability
Moderna, Inc. · 2026-11-06 · Importance 79 · Surprise 82 · In source text
Moderna reported third-quarter 2026 net income of $162 million, compared with a $200 million net loss in the third quarter of 2025, a $362 million year-over-year improvement. Diluted EPS was $0.38, compared with a loss per share of $0.51 a year earlier. Income from operations was $130 million in the quarter, compared with an operating loss of $260 million in the prior-year period.
Key facts
- Moderna's third-quarter 2026 net income was $162 million, compared with a net loss of $200 million in third-quarter 2025, a $362 million year-over-year improvement. source
- Moderna's third-quarter 2026 diluted EPS was $0.38, compared with a loss per share of $0.51 in third-quarter 2025. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | positive | realized | +249.7% | Moderna's third-quarter 2026 net income was $162 million, compared with a net loss of $200 million in third-quarter 2025, a $362 million… |